[1]陈雪琴,宋志强.银屑病中主要免疫细胞和相关细胞因子的研究进展[J].中国皮肤性病学杂志,2020,(11):1321-1325.[doi:10.13735/j.cjdv.1001-7089.201910054]
 CHEN Xueqin,SONG Zhiqiang.Progress of Research on Main Immune Cells and Related Cytokines in Psoriasis[J].The Chinese Journal of Dermatovenereology,2020,(11):1321-1325.[doi:10.13735/j.cjdv.1001-7089.201910054]
点击复制

银屑病中主要免疫细胞和相关细胞因子的研究进展()
分享到:

《中国皮肤性病学杂志》[ISSN:1001-7089/CN:61-1197/R]

卷:
期数:
2020年11期
页码:
1321-1325
栏目:
综述
出版日期:
2020-11-01

文章信息/Info

Title:
Progress of Research on Main Immune Cells and Related Cytokines in Psoriasis
文章编号:
1001-7089(2020)11-1321-05
作者:
陈雪琴宋志强
陆军军医大学(第三军医大学)西南医院皮肤科,重庆400038
Author(s):
CHEN XueqinSONG Zhiqiang
Department of Dermatology,First Hospital Affiliated to Army Military Medical University,Southwest Hospital,Chongqing 400038,China
关键词:
银屑病 发病机制 Th17 IL-17
Keywords:
Psoriasis Pathogenesis Th17 IL-17
分类号:
R 758.63
DOI:
10.13735/j.cjdv.1001-7089.201910054
文献标志码:
A
摘要:
银屑病是一种常见并易复发的慢性炎症性皮肤病。本病的确切病因尚未清楚,Th1和Th17介导的慢性炎症反应、表皮过度增殖和慢性新血管生成是目前被广泛认可的发病机制,阻断TNF-α和IL-23/Th17相关途径的生物制剂是迄今为止治疗银屑病最有效的药物。然而,尽管生物制剂治疗方面取得了较好的进展,但仍无法完全满足银屑病治疗上的需要,提示目前对银屑病潜在发病机制仍存在认识上的盲点。因此,本综述主要关注包括Th17细胞及其他参与银屑病发病机制的重要效应细胞(中性粒细胞、单核细胞和肥大细胞)以及相关细胞因子的研究进展,以便更全面了解银屑病的发病机制,为银屑病的治疗提供理论依据。
Abstract:
Psoriasis is a common and recurrent chronic inflammatory skin disease.The exact etiology of this disease is not clear.Th1 and Th17 mediated chronic inflammatory response,epidermal hyperproliferation and chronic neovascularization are widely recognized pathogenesis.Biological agents blocking TNF-α and IL-23/Th17 related pathways are the most effective drugs to treat psoriasis so far.However,despite the good progress in biological agent therapy,it still can not fully meet the needs of psoriasis treatment,suggesting that there is still a blind spot in understanding the potential pathogenesis of psoriasis.Therefore,this review mainly focuses on the research progress of Th17 cells and other important effector cells(neutrophils,monocytes and mast cells)and related cytokines involved in the pathogenesis of psoriasis,so as to understand the pathogenesis of psoriasis more comprehensively and provide theoretical basis for the treatment of psoriasis.

参考文献/References:

[1] Harden JL,Krueger JG,Bowcock AM.The immunogenetics of psoriasis:a comprehensive review[J].J Autoimmun,2015,64(7):66-73.
[2] Liang Y,Sarkar MK,Tsoi LC,et al.Psoriasis:a mixed autoimmune and auto inflammatory disease[J].Curr Opin Immunol,2017,49(7):1-8.
[3] 王超颖,张慧敏.银屑病发病机制研究新进展[J].世界最新医学信息文摘,2019,19(60):28-31.
[4] Griffiths CE,Strober BE,Vand KP,et al.Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis[J].N Engl J Med,2010,36(2):118.
[5] Lebwohl M,Strober B,Menter A,et al.Phase 3 studies comparing brodalumab with ustekinumab in psoriasis[J].N Engl J Med,2015,373(14):1318-1328.
[6] Reich K,Papp KA,Matheson RT,et al.Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis[J].Exp Dermatol,2015,24(7):529-535.
[7] Senra L,Stalder R,Alvarez Martinez D,et al.Keratinocyte-derived IL-17E contributes to inflammation in psoriasis[J].J Invest Dermatol,2016,136(10):1970-1980.
[8] Keijsers RR,Hendriks AG,van Erp PE,et al.In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORgammat and IL-17[J].J Invest Dermatol,2014,134(5):1276-1284.
[9] Taylor PR,Roy S,Leal SM,et al.Activation of neutrophils by autocrine IL-17AIL-17RC interactions during fungal infection is regulated by IL-6,IL-23,ROR gammat and dectin-2[J].Nat Immunol,2014,15(2):143-151.
[10] Brembilla NC,Stalder R,Senra L,et al.IL-17A localizes in the exocytic compartment of mast cells in psoriatic skin[J].Br J Dermatol,2017,177(5):1458-1460.
[11] 尹莉,尹志强.白介素-17家族与银屑病[J].中国麻风皮肤病杂志,2017,33(1):59-61.
[12] Noordenbos T,Blijdorp I,Chen S,et al.Human mast cells capture,store,and release bioactive,exogenous IL-17A[J].J Leukoc Biol,2016,100(3):453-462.
[13] Dudeck A,Suender CA,Kostka SL,et al.Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function[J].Eur J Immunol,2011,41(7):1883-1893.
[14] Georgescu SR,Tampa M,Caruntu C,et al.Advances in understanding theimmunological pathways in psoriasis[J].Int J Mol Sci,2019,20(3):739.
[15] Volaric'I,Vicˇic'M,Prpic'-Massari L.The role of CD8+T-cells and their cytokines in the pathogenesis of psoriasis[J].Acta Dermatovenerol Croat,2019,27(3):159-162.
[16] 罗素菊.Th22及其细胞因子与银屑病表达HB-EGF的关系[J].中国医学文摘·皮肤科学,2015,32(6):686-689.
[17] Benhadou F,Mintoff D,Del Marmol V.Psoriasis:keratinocytes or immune cells-which is the trigger?[J].Dermatology,2019,235(2):91-100.
[18] 李晓倩,孙海英,乔建林,等.Th9细胞和白细胞介素-9在自身免疫性疾病中的研究进展[J].国际免疫学杂志,2016,39(2):163-167.
[19] 陈建霞,冯燕艳.巨噬细胞在银屑病发病机制中作用的研究进展[J].临床皮肤科杂志,2019,48(11):714-716.
[20] Fujishima S,Watanabe H,Kawaguchi M,et al.Involvement of IL-17F via the induction of IL-6 in psoriasis[J].Arch Dermatol Res,2010,302(7):499-505.
[21] Glatt S,Helmer E,Haier B,et al.First-in-human randomized study of bimekizumab,a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F,in mild psoriasis[J].Br J Clin Pharmacol,2017,83(5):991-1001.
[22] Johnston A,Fritz Y,Dawes SM,et al.Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation[J].J Immunol,2013,190(5):2252-2262.
[23] Kim BE,Bin L,Ye YM,et al.IL-25 enhances HSV-1 replication by inhibiting filaggrin expression,and acts synergistically with Th2 cytokines to enhance HSV-1 replication[J].J Invest Dermatol,2013,133(12):2678-2685.
[24] Batalla A,Coto E,Gonzalez-Lara L,et al.Association between single nucleotide polymorphisms IL-17RA rs4819554 and IL-17E rs79877597 and psoriasis in a Spanish cohort[J].J Dermatol Sci,2015,80(2):111-115.
[25] Gaffen SL,Jain R,Garg AV,et al.The IL-23-IL-17 immune axis:from mechanisms to therapeutic testing[J].Nat Rev Immunol,2014,14(9):585-600.
[26] Johnson-Huang LM,Suarez-Farinas M,Pierson KC,et al.A single intradermal injection of IFN-gamma induces an inflammatory state in both non-lesional psoriatic and healthy skin[J].J Invest Dermatol,2012,132(4):1177-1187.
[27] Harden JL,Krueger JG,Bowcock AM.The immunogenetics of psoriasis:a comprehensive review[J].J Autoimmun,2015,64(7):66-73.
[28] Schlapbach C,Gehad A,Yang C,et al.Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity[J].Sci Transl Med,2014,6(219):219ra8.

相似文献/References:

[1]唐娟,张晓艳,宋佩华,等.寻常性银屑病患者皮损及外周血单一核细胞中IL-17A的表达[J].中国皮肤性病学杂志,2012,(08):689.
 TANG Juan,ZHANG Xiao-yan,SONG Pei-hua,et al.Expression of IL-17A in Involved Lesions and Blood Mononuclear Cells of Patients with Psoriaisis[J].The Chinese Journal of Dermatovenereology,2012,(11):689.
[2]戴莎,王秀丽,宋心葵,等.银屑病患者410例合并代谢综合征分析[J].中国皮肤性病学杂志,2012,(08):700.
 DAI Sha,WANG Xiu-li,SONG Xin-kui,et al.Analysis of 410 Cases of Psoriasis Patients with Metabolic Syndrome[J].The Chinese Journal of Dermatovenereology,2012,(11):700.
[3]谢韶琼,汪青良,宋勋,等.凉血润肤汤治疗寻常性银屑病42例疗效观察[J].中国皮肤性病学杂志,2012,(08):743.
 XIE Shao-qiong,WANG Qing-liang,SONG Xun,et al.Clinical Observation of Liangxierunfu Decoction on 42 Cases of Psoriasis Vulgaris[J].The Chinese Journal of Dermatovenereology,2012,(11):743.
[4]广维,朱红,姚树兰,等.伊那西普治疗银屑病的十年回顾[J].中国皮肤性病学杂志,2012,(08):745.
 GUANG Wei,ZHU Hong,YAO Shu-lan,et al.A 10-year Review of Etanercept in the Treatment of Psoriasis[J].The Chinese Journal of Dermatovenereology,2012,(11):745.
[5]史航,刘晓明,林熙然,等.银屑病发病与创伤愈合机制的比较[J].中国皮肤性病学杂志,2012,(08):748.
 SHI Hang,LIU Xiao-ming,LIN Xi-ran.A Comparison on Pathogenesis of Psoriasis and Mechanism of Wound Healing[J].The Chinese Journal of Dermatovenereology,2012,(11):748.
[6]刘晓洁,张峻岭,刘雪,等.头皮银屑病和脂溢性皮炎的皮肤镜特征分析[J].中国皮肤性病学杂志,2015,(01):36.[doi:10.13735/j.cjdv.1001-7089.2015.0036]
 LIU Xiao jie,ZHANG Jun ling,LIU Xue,et al.Analysis of Dermoscopic Criteria for Scalp Psoriasis and Scalp Seborrheic Dermatitis[J].The Chinese Journal of Dermatovenereology,2015,(11):36.[doi:10.13735/j.cjdv.1001-7089.2015.0036]
[7]王彩梅,汤洁,向志,等.甲损害在泛发性脓疱型银屑病中的临床意义[J].中国皮肤性病学杂志,2015,(01):44.[doi:10.13735/j.cjdv.1001-7089.2015.0044]
 WANG Cai mei,TANG Jie,XIANG Zhi,et al.Clinical Significance of Nail Involvement in Generalized Pustular Psoriasis[J].The Chinese Journal of Dermatovenereology,2015,(11):44.[doi:10.13735/j.cjdv.1001-7089.2015.0044]
[8]李珺莹,李红.酪氨酸激酶及其抑制剂与免疫性皮肤病的研究进展[J].中国皮肤性病学杂志,2015,(01):93.[doi:10.13735/j.cjdv.1001-7089.2015.0093]
 LI Jun ying,LI Hong.Tyrosine Kinases and its Inhibitors in Immune Dermatologic Diseases[J].The Chinese Journal of Dermatovenereology,2015,(11):93.[doi:10.13735/j.cjdv.1001-7089.2015.0093]
[9]段茜,程燕,储蕾,等.银屑病与高血压病的相关性分析[J].中国皮肤性病学杂志,2015,(02):143.[doi:10.13735/j.cjdv.1001-7089.201404140]
 DUAN Xi,CHENG Yan,CHU Lei,et al.The Correlation between Psoriasis and Hypertension[J].The Chinese Journal of Dermatovenereology,2015,(11):143.[doi:10.13735/j.cjdv.1001-7089.201404140]
[10]杨颜龙,张禁,易松柏,等.阿维A胶囊联合复方甘草酸苷注射液治疗红皮病型银屑病30例临床观察[J].中国皮肤性病学杂志,2015,(02):217.[doi:10.13735/j.cjdv.1001-7089.201403167]
 YANG Yan long,ZHANG Jin,YI Song bai,et al.Clinical Observation of 30 Acitretin Capsules Combine with Compound Glycyrrhizin Injection in the Treatment of Patients with Erythrodermic Psoriasis[J].The Chinese Journal of Dermatovenereology,2015,(11):217.[doi:10.13735/j.cjdv.1001-7089.201403167]
[11]刘萌,段琪琪,王敏,等.基于生物信息学分析探究银屑病关键基因和通路[J].中国皮肤性病学杂志,2019,(11):1232.[doi:10.13735/j.cjdv.1001-7089.201903031]
 LIU Meng,DUAN Qiqi,WANG Min,et al.Identification of Key Gene and Pathways in Psoriasis Based on Bioinformatics Analysis[J].The Chinese Journal of Dermatovenereology,2019,(11):1232.[doi:10.13735/j.cjdv.1001-7089.201903031]

备注/Memo

备注/Memo:
[基金项目] 陆军军医大学西南医院创新团队培养计划(SWH2018TD-02) [通信作者] 宋志强,E-mail:zhiqiang.song@hotmail.com
更新日期/Last Update: 2020-11-16